NM_000518.5:c.*112A>G
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PM2PP5_ModerateBP4
The NM_000518.5(HBB):c.*112A>G variant causes a 3 prime UTR change. The variant allele was found at a frequency of 0.00000116 in 859,910 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000518.5 3_prime_UTR
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000116 AC: 1AN: 859910Hom.: 0 Cov.: 12 AF XY: 0.00000221 AC XY: 1AN XY: 451864
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
beta Thalassemia Pathogenic:1
Variant summary: HBB c.*112A>G is located in the untranslated mRNA region downstream of the termination codon. The variant was absent in 31396 control chromosomes (gnomAD). c.*112A>G has been reported in the literature in multiple individuals affected with Beta Thalassemia (e.g. Jankovic_1990, Huisman_1997, Phylipsen_2010, Rahim_2015, Lim_2016). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 2375910, 9342003, 1856830, 27821013, 26554253, 20110179). ClinVar contains an entry for this variant (Variation ID: 15476). Based on the evidence outlined above, the variant was classified as pathogenic. -
Beta-plus-thalassemia Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at